Spotlight On... Candidate Clinton calls for $2B in annual Alzheimer's R&D support; Drug combo reduces pain symptoms in animal model; Researchers find link on prostate cancer; and much more...

Alzheimer's drug research has been one of the toughest fields in R&D, claiming a host of clinical trial failures. And now it's becoming an issue in the race for the White House. Democratic candidate Hillary Clinton wants to spend $2 billion a year on R&D activities in Alzheimer's over the next 10 years as millions of patients and their families deal with the memory-stealing malady. That's more than double the current spending. Story (sub. req.)

> A new report from Northwestern Medicine says one region of the brain is remodeled by pain, and a new combination therapy was used to restore it and reduce pain symptoms in an animal model. Release

> Researchers at the University of Virginia School of Medicine say an unexpected link between radiation and androgen ablation may point to a better approach on prostate cancer. Release

> Penn State College of Medicine researchers say that an MRI contrast agent that can slip through the blood-brain barrier may help diagnose gliomas earlier. Release

Suggested Articles

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.

Dutch scientists used stem cells from CF patients to demonstrate a technique that corrects a mutation in the gene CFTR without having to cut DNA.

A new map of the thymus gland could help researchers understand how T cells develop and inspire treatments for cancer and autoimmune disease.